En Es
Categories

Industry News

Canon Medical Systems Initiates Collaborative Research On AI in MR Imaging

By Medimaging International staff writers
05 Apr 2018

Image: Canon Medical Systems has initiated collaborative research on the application of AI-based technology in magnetic resonance imaging (Photo courtesy of iStock).Canon Medical Systems Corporation (Otawara, Tochigi Prefecture, Japan), along with Kumamoto University (Kumamoto Prefecture, Kurokami, Japan) and the University of Bordeaux (Bordeaux, Nouvelle-Aquitaine, France), has initiated collaborative research on the application of Deep Learning Reconstruction (DLR), an Artificial Intelligence (AI)-based technology in magnetic resonance (MR) imaging.

DLR is a reconstruction technology that utilizes deep learning technology to eliminate noise from images. The technology analyzes the relationship between noisy and less noisy images using a computer-generated model, making it possible to eliminate noise from newly acquired images. DLR is capable of acquiring high-resolution images, as well as allowing ultra-high-resolution images to be acquired more quickly in comparison to conventional imaging methods. As a result, the potential applications of this ultra-high-resolution imaging technology in the clinical setting have been attracting significant interest.

Additionally, in comparison to a standard smoothing filter, the noise elimination method employed in DLR causes only a slight reduction in image quality, and signal variation in organ parenchyma is minimized. This improves the image quality and helps to increase accuracy in quantitative analysis, which is easily affected by noise. Hence, DLR is considered as a major technological advance that can dramatically change how MRI examinations will be performed in the future. The combination of the latest AI technology with next-generation MRI scanners is expected to be useful in eliminating noise and improving image quality, as well as in a wide variety of MR-related fields.

“DLR has the potential to transform the conventional concept of MR imaging and is expected to allow the acquisition of super-high-resolution images in a shorter time and contribute to more accurate quantitative analysis,” said Professor Yasuyuki Yamashita of the Department of Diagnostic Radiology, Faculty of Life Science, Kumamoto University.

“When DLR is used in combination, the ultra-high-resolution images acquired using the latest 3-T MRI system from Canon Medical Systems (installed last November) are comparable to images acquired using a 7-T MRI system. This suggests that DLR may be able to take the place of some high-field conventional MRI studies,” added Professor Vincent Dousset, Institut de Bio-Imagerie Université de Bordeaux, Chef de Service Neuro-Imagerie CHU de Bordeaux.

“We are very proud to have started this cutting-edge collaborative research which will lead to the development of next-generation MRI technology at leading medical institutions both in and outside Japan. We anticipate that this research will prove to be of great value by providing higher-resolution images for clinical diagnosis,” said President Takiguchi of Canon Medical Systems Corporation.



E-mail Print
FaceBook Twitter Google+ Linked in

CANON

Canon U.S.A., Inc. provides digital imaging solutions for the healthcare sector, including digital detectors, digital radiography / fluoroscopy solutions, mobile & portable solutions, acquisition carts, and software solutions.
More info

More articles about CANON

09 Jan 2018
Toshiba Medical Systems Changes Name to Canon Medical Systems
The official corporate name of Toshiba Medical Systems Corporation has been changed to Canon Medical Systems Corporation. The name change follows the completion of procedures for obtaining regulatory approval for integration with the Canon Group after the company officially became a subsidiary of Canon Inc. in December 2016. Similarly, Toshiba America Medical Systems, now a Canon group company, has been officially named as Canon Medical Systems USA, Inc.
Read More
22 Dec 2016
Canon Completes Acquisition of Toshiba Medical
Japanese electronics manufacturer Canon Inc. has completed its acquisition of Toshiba Medical Systems Corp., a medical unit of Toshiba Corp. that provides medical imaging products and solutions. Canon has received the necessary clearance from competition regulatory authorities to make Toshiba Medical its subsidiary in a USD 54.7 billion deal.
Read More

Additional news

23 Nov 2018
AI Predicts Alzheimer’s Disease Years before Diagnosis
A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.
Read More
23 Nov 2018
UK to Set Up New GBP 10 Million Centre for Medical Imaging and AI
The UK’s London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare will train sophisticated artificial intelligence (AI) algorithms from NHS medical images and patient data, to create tools that will help clinicians speed up and improve diagnosis and care across a number of patient pathways, including dementia, heart failure and cancer.
Read More
23 Nov 2018
New AI Algorithm Enhances Polyp Detection in Colonoscopy Procedures
Researchers at Shanghai Wision AI Co., Ltd., a developer of computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging, have announced results of a study validating a novel machine-learning algorithm that improves detection of adenomatous polyps during colonoscopy. The AI algorithm is built on the same network architecture that is used to develop self-driving cars and is designed to enable “self-driving” in colonoscopy procedures.
Read More
20 Nov 2018
Study Finds AI Falls Short When Analyzing Medical Data
A study conducted at the Icahn School of Medicine at Mount Sinai has found that artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems. These findings suggest that unless AI in the medical space is carefully tested for performance across a wide range of populations, the deep learning models may not perform as accurately as expected.
Read More
20 Nov 2018
New AI Software for Brain Bleed Diagnosis Receives FDA Clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to the Accipio Ix intracranial hemorrhage (ICH) detection software developed by MaxQ AI, a clinical diagnostics intelligence platform company.
Read More
20 Nov 2018
Global Refurbished Medical Devices Market to Increase by 10% by 2023
The global refurbished medical devices market is expected to grow at a CAGR of over 10% during the forecast period 2019-2023, driven by the organized healthcare ecosystem in the developed economies. Moreover, privatization in the healthcare sector is increasing rapidly due to the inability of governments to invest efficiently in the sector, coupled with high demand for innovation and technology for superior healthcare services.
Read More
12 Nov 2018
ACR Data Science Institute Releases AI Use Cases to Accelerate AI Adoption
The American College of Radiology Data Science Institute has released a first-of-its-kind series of standardized artificial intelligence (AI) use cases that will accelerate medical imaging AI adoption. This continually updated, freely available use case series is the product of a previously missing and collaborative framework that enables efficient creation, implementation and ongoing improvement of radiological AI tools.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
12 Nov 2018
OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad, a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions